Filings · News reference

Shah Capital Cuts Novavax Stake To 6.39%, Sells 2.87M Shares At Average Price Of $11.35/Share, Restructures Holdings Into Family Office

Oct 16, 2026, 8:26 PMBenzinga Newsdesk

More filings news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: benzinga
Observed: Oct 16, 2026, 8:26 PM
Checked: Oct 16, 2026, 8:26 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaOct 16, 2026, 8:24 PMBenzinga Newsdesk
Shah Capital Filed To Voluntarily Withdraw Its Registration As An Investment Adviser With SEC, Effective Oct. 16; Shah Capital No Longer Holds Novavax Shares With Purpose Of Influencing Control, Intends To Report On Schedule 13G Going Forward
https://www.sec.gov/Archives/edgar/data/1000694/000139834426018323/xslSCHEDULE_13D_X02/primary_doc.xml
NVAX
BenzingaOct 15, 2026, 5:04 PMBenzinga Newsdesk
Citigroup Maintains Sell on Novavax, Raises Price Target to $8
Citigroup analyst Geoff Meacham maintains Novavax (NASDAQ:NVAX) with a Sell and raises the price target from $7 to $8.
NVAX
BenzingaOct 12, 2026, 9:12 AMAnanya Gairola
Stephen King Slams Trump’s New Press Secretary as Past Vaccine Conspiracy Theories, Third-Term Posts Spark Fresh Controversy: 'She Appears to Have Tried to…'
Stephen King slammed Trump’s incoming press secretary over her vaccine conspiracy theories and controversial posts.
DJT LLY MRK MRNA NVAX